Merck & Company Inc
MRK
New York Stock Exchange. Currency in USD
109.44 +0.24 ( +0.22% )
Market Cap.
277.47B
Beta (5Y monthly)
0.41
Price/Earnings
14.47
EPS (TTM)
7.66
Forward Dividend
2.92 (2.62%)
Ex-Dividend Date
Dec 14, 2022
Volume
6.93M
1y Target Est.
110.70
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
5.00%
YTD
42.80%
1Y
44.59%
2Y
37.61%
17.32% ann.
3Y
21.61%
6.74% ann.
5Y
94.63%
14.25% ann.
10Y
150.66%
9.63% ann.
EPS growth
1Y
32.53%
2Y
32.76%
15.23% ann.
3Y
51.08%
14.74% ann.
5Y
96.92%
14.52% ann.
10Y
93.43%
6.82% ann.
20Y
155.33%
4.80% ann.
Share Buybacks
3 Months
-0.08%
6 Months
-0.20%
1Y
-0.24%
2Y
-0.16%
3Y
1.17%
5Y
6.78%
10Y
17.31%
20Y
-12.19%
About Merck & Company Inc
Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.merck.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.53B
Employees
67000
Address
2000 Galloping Hill Road, Kenilworth, NJ, United States, 07033
Latest news

What's Going On With Moderna Stock Monday?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday following positive analyst coverage from Jefferies....
By Benzinga - 6 weeks ago

The Zacks Analyst Blog Highlights Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant
Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant are part of the Zacks top Analyst Blog.
By Zacks Investment Research - 6 weeks ago

Are These Multibillion-Dollar Vaccine Stocks Still a Buy?
Moderna and Merck are up on the news regarding their melanoma cancer vaccine.
By The Motley Fool - 6 weeks ago
This momentum-stock strategy can be a winner regardless of whether the Federal Reserve pivots
A strategy of holding stocks that have been on an upswing has outperformed the S&P...
By MarketWatch - 6 weeks ago

FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
The FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for Lynparza's...
By Zacks Investment Research - 7 weeks ago

Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
Eli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based...
By Zacks Investment Research - 7 weeks ago

4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023
Here are four drug companies, MRK, VRTX, IMCR and IMVT, that are up 40% or...
By Zacks Investment Research - 7 weeks ago

2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing...
By The Motley Fool - 7 weeks ago